ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
2,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
4,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
4,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5,1,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
7,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
7,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
7,4,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,Y
7,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
7,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8,1,Pseudolymphoma,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
8,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
10,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
11,1,Arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
12,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
12,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12,3,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
12,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
13,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
14,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
15,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
15,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
15,3,Tourette's disorder,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
16,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
17,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
17,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
17,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
17,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
17,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
18,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
18,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
19,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
19,2,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
19,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
20,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
20,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
21,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
21,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
22,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
23,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
23,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
24,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
24,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
25,1,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
26,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
26,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
27,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
28,1,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
28,2,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
29,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
29,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
30,1,Choreoathetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
31,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
32,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
33,1,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
33,2,Congenital musculoskeletal disorder of skull,Musculoskeletal and connective tissue disorders of skull congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
34,1,Foetal anticonvulsant syndrome,Chemically-induced congenital syndromes,Congenital and hereditary disorders NEC,Cong,N
35,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,Y
35,2,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
35,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
36,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
37,1,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
37,2,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
38,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
39,1,Cerebellar ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
39,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
40,1,Nodular regenerative hyperplasia,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
41,1,Motor neurone disease,Motor neurone diseases,Neuromuscular disorders,Nerv,Y
42,1,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
43,1,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
44,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
44,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
45,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
46,1,Lip oedema,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
47,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
47,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
47,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
48,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
48,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
49,1,Glomerulonephritis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
50,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
51,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
52,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
52,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
52,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
53,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
54,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
55,1,Enuresis,Psychiatric elimination disorders,Psychiatric disorders NEC,Psych,N
56,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
57,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
58,1,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
59,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
60,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
60,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
60,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
60,4,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
61,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
62,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
63,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
63,2,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
63,3,Mucous stools,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
63,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
64,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
64,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
65,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
66,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
67,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
67,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
68,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
69,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
69,2,Dysdiadochokinesis,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
69,3,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
70,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
71,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
72,1,Anaemia macrocytic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
73,1,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
74,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
74,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
75,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
75,2,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
76,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,Y
77,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
78,1,Renal cancer,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
79,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
79,2,Headache,Headaches NEC,Headaches,Nerv,N
79,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
80,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
81,1,Limb reduction defect,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
82,1,Cerebellar atrophy,Structural brain disorders NEC,Structural brain disorders,Nerv,N
82,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
83,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
84,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
84,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
84,3,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
85,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
85,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
85,3,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
85,4,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
86,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
86,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
86,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
86,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
86,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
86,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
86,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
87,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
87,2,Sinus arrest,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
88,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
89,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
90,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
91,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
91,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
91,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
91,4,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
91,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
92,1,Renal neoplasm,Urinary tract neoplasms unspecified malignancy NEC,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
93,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
93,2,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
93,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
93,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
93,5,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
94,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
95,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
96,1,Toxic skin eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,Y
97,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
98,1,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
99,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
100,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
101,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
102,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
103,1,Axillary vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
104,1,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
105,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
106,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
106,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
107,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
108,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
109,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
110,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
110,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
110,3,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
111,1,Anencephaly,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
112,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
113,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
114,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
114,2,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
115,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
116,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
117,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
118,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
119,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
119,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
119,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
119,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
119,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
119,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
119,7,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
120,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
120,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
121,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
122,1,Rhinophyma,Rosaceas,Skin appendage conditions,Skin,N
123,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
123,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
124,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
125,1,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
126,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
127,1,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
128,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
128,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
128,3,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
128,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
129,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
130,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
130,2,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
130,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
131,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
131,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
132,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
133,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
134,1,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
135,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
135,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
135,3,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
136,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
136,2,Osteomalacia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
137,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
138,1,Anaemia macrocytic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,Y
138,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
139,1,Anaemia macrocytic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,Y
140,1,Anaemia macrocytic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,Y
140,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
141,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,Y
142,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
142,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
143,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
144,1,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,Y
145,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
146,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
147,1,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
148,1,Abortion,Abortions not specified as induced or spontaneous,Abortions and stillbirth,Preg,N
149,1,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
149,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
149,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
150,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
150,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
151,1,Neonatal respiratory acidosis,Newborn respiratory disorders NEC,Neonatal respiratory disorders,Resp,N
151,2,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
152,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
152,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
153,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
154,1,Deafness,Hearing losses,Hearing disorders,Ear,N
155,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
156,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,Y
157,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
157,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
158,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
158,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
159,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
159,2,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
160,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,Y
160,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
161,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
161,2,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
161,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
162,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
162,2,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
163,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
164,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
165,1,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
166,1,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
167,1,Acne,Acnes,Skin appendage conditions,Skin,N
168,1,Hypoplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
169,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
169,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
169,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
169,4,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
170,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
171,1,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
172,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
172,2,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
172,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
173,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
174,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
174,2,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
174,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
174,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
174,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
175,1,Anaemia folate deficiency,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
176,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
177,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
177,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
178,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
179,1,Retroperitoneal fibrosis,Peritoneal and retroperitoneal fibrosis and adhesions,Peritoneal and retroperitoneal conditions,Gastr,N
180,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
180,2,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
181,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
181,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
182,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,Y
182,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
183,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
183,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
184,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
185,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
186,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
187,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
187,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
187,3,Electric shock sensation,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
188,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
189,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
190,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
190,2,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
191,1,Atrial tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
191,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
192,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
193,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
194,1,Congenital eye disorder,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
194,2,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
195,1,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
196,1,Multiple congenital abnormalities,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
197,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
198,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
198,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
199,1,Multiple congenital abnormalities,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
200,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
201,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
202,1,Osteomalacia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
203,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
203,2,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
203,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
203,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
204,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
204,2,Osteomalacia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
205,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
206,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
207,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
207,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
208,1,Cerebellar syndrome,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
209,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
210,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
211,1,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
211,2,Multiple congenital abnormalities,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
212,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
212,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
212,3,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
213,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
214,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
215,1,Headache,Headaches NEC,Headaches,Nerv,N
216,1,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
216,2,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
217,1,Renal aplasia,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
218,1,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
219,1,Osteomalacia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
220,1,Abortion,Abortions not specified as induced or spontaneous,Abortions and stillbirth,Preg,N
220,2,Anencephaly,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
221,1,Syndactyly,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
222,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
222,2,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
222,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
223,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
223,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
224,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
225,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
225,2,Myopathy,Myopathies,Muscle disorders,Musc,N
226,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
226,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
227,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
228,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
228,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
228,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
229,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
230,1,Folate deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
231,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
231,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
232,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
232,2,Fibrosarcoma,Fibrosarcomas malignant,Soft tissue neoplasms malignant and unspecified,Neopl,N
233,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
233,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
233,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
234,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
234,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
234,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
235,1,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
236,1,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
236,2,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
237,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
238,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
239,1,Congenital musculoskeletal disorder,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
240,1,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
241,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
241,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
242,1,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
242,2,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
242,3,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
242,4,Urinary tract malformation,Renal and urinary tract disorders congenital NEC,Renal and urinary tract disorders congenital,Cong,N
243,1,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
243,2,Ventricular septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
243,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
244,1,Neonatal respiratory distress syndrome,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
245,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
246,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
247,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
247,2,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
247,3,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
247,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
248,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
248,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
248,3,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
248,4,Headache,Headaches NEC,Headaches,Nerv,N
248,5,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
249,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
249,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
250,1,Congenital musculoskeletal disorder,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
251,1,Hypospadias,Male reproductive tract disorders congenital,Reproductive tract and breast disorders congenital,Cong,N
252,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
253,1,Hypospadias,Male reproductive tract disorders congenital,Reproductive tract and breast disorders congenital,Cong,N
254,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
254,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
254,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
254,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
255,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
256,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
257,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
258,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
258,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
259,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
259,2,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
259,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
259,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
260,1,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
260,2,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
261,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
262,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
262,2,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
262,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
262,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
263,1,Anaemia macrocytic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
264,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
264,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
265,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
266,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
266,2,Nipple pain,Breast signs and symptoms,Breast disorders,Repro,N
267,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
268,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
269,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
269,2,Sideroblastic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
270,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
270,2,Sideroblastic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
271,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
272,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,Y
273,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
274,1,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
275,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
275,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
276,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
276,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
277,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
277,2,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
277,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
277,4,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
277,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
278,1,Multiple congenital abnormalities,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
279,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
280,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
280,2,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
280,3,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
281,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
281,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
281,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
282,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
282,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
282,3,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
283,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
284,1,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
285,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
285,2,Muscle spasticity,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
286,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
287,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
288,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
289,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
289,2,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
289,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
289,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
290,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
291,1,Amblyopia,Amblyopic vision impairment,Vision disorders,Eye,N
291,2,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
292,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
292,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
293,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,Y
294,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,Y
295,1,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
296,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
296,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
296,3,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
296,4,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
297,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
298,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
299,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
300,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
300,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
300,3,Gingival swelling,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
300,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
300,5,Systemic lupus erythematosus rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
301,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
302,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
303,1,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
304,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
304,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
305,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
305,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
305,3,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
306,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
307,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
308,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
308,2,Headache,Headaches NEC,Headaches,Nerv,N
308,3,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
309,1,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
310,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
310,2,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
310,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
311,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
312,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
312,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
312,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
312,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
312,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
313,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
314,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
315,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
316,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
317,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
318,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
319,1,Congenital musculoskeletal disorder,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
320,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
321,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
322,1,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
323,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
323,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
324,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
324,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
325,1,Polycythaemia,Polycythaemia (excl rubra vera),Red blood cell disorders,Blood,N
326,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
327,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
327,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
327,3,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
328,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
329,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
330,1,Congenital musculoskeletal disorder,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
331,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
331,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
332,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
332,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
332,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
332,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
333,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
333,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
334,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
334,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
335,1,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
336,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
337,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
338,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
339,1,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
339,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
340,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
340,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
340,3,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
341,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
342,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
343,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
344,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
345,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
345,2,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
346,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
346,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
347,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
347,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
348,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
349,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
350,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
351,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
352,1,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
353,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
354,1,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
355,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
355,2,Prostatic disorder,"Prostatic signs, symptoms and disorders NEC",Prostatic disorders (excl infections and inflammations),Repro,N
356,1,Choreoathetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
357,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
358,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
359,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
359,2,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
360,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
360,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
360,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
360,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
361,1,Gastrointestinal malformation,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
362,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
362,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
363,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
364,1,Congenital musculoskeletal disorder,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
364,2,Multiple congenital abnormalities,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
365,1,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
365,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
366,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
367,1,Congenital musculoskeletal disorder,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
368,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
368,2,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
369,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
370,1,Granuloma,Inflammations,General system disorders NEC,Genrl,N
370,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
371,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
371,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
371,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
372,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
373,1,Mastitis,Breast infections,Infections - pathogen unspecified,Infec,N
374,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
375,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
375,2,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
375,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
375,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
375,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
376,1,Congenital musculoskeletal disorder,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
376,2,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
377,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
377,2,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
377,3,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
377,4,Osteomalacia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
378,1,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
379,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
380,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
381,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
382,1,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
383,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
384,1,Hypospadias,Male reproductive tract disorders congenital,Reproductive tract and breast disorders congenital,Cong,N
385,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
385,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
385,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
385,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
386,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
387,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
387,2,Hypochromic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
388,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
389,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
390,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
390,2,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
391,1,Osteomalacia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
392,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
393,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
394,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
394,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
394,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
395,1,Parotid gland enlargement,Salivary gland enlargements,Salivary gland conditions,Gastr,N
396,1,Alanine aminotransferase,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
396,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
396,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
396,4,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
396,5,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
396,6,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
397,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
398,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
398,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
399,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
399,2,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
400,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
401,1,Congenital musculoskeletal disorder,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
402,1,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
402,2,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
403,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
404,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
404,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
405,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
405,2,Upper motor neurone lesion,Motor neurone diseases,Neuromuscular disorders,Nerv,N
406,1,Enterocolitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
407,1,Congenital musculoskeletal disorder of limbs,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
408,1,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
408,2,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
408,3,Congenital musculoskeletal disorder,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
408,4,Multiple congenital abnormalities,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
408,5,Ventricular septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
409,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
409,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
410,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
410,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
411,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
411,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
411,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
412,1,Atrial septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
412,2,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
412,3,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
412,4,Ventricular septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
413,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
414,1,Choreoathetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
415,1,Folate deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
415,2,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
415,3,Vitamin B12 deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
416,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
416,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
417,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
418,1,Congenital eye disorder,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
419,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
420,1,Globulins increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
420,2,Immunoglobulins abnormal,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
420,3,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
420,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
420,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
420,6,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
421,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
422,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
423,1,Congenital musculoskeletal disorder of limbs,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
424,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
424,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
424,3,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
424,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
424,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
425,1,Anaemia macrocytic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
426,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
427,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
427,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
427,3,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
428,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
428,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
429,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
430,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
430,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
430,3,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
431,1,Asphyxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,Y
432,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
433,1,Hepatitis fulminant,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
434,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
434,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
434,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
435,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
436,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
436,2,Headache,Headaches NEC,Headaches,Nerv,N
436,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
436,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
436,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
436,6,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
436,7,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
437,1,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
438,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
439,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
439,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
439,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
439,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
439,5,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
439,6,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
439,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
439,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
440,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
440,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
440,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
441,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
442,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
442,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,Y
442,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
443,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
444,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
444,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
445,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
445,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
445,3,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
445,4,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
445,5,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
445,6,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
446,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
447,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
448,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
448,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
448,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
448,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
449,1,Parotitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
450,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
450,2,Pseudolymphoma,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
451,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
452,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
452,2,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
452,3,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
453,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
454,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
455,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
455,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
455,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
456,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
457,1,Myopathy,Myopathies,Muscle disorders,Musc,N
457,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
458,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
458,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
459,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
459,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
459,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
460,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
461,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,Y
462,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
463,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
464,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
465,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
466,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
466,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
467,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
468,1,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
469,1,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
470,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
471,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
472,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
472,2,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
473,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
474,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
475,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
475,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
475,3,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
475,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
475,5,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
476,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
477,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
478,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
479,1,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
479,2,Congenital musculoskeletal disorder,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
480,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
481,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
481,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
482,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
483,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
483,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
484,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
484,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
484,3,Foreign body sensation in eyes,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
485,1,Cerebellar syndrome,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
486,1,Congenital nail disorder,Hair and nail disorders congenital,Skin and subcutaneous tissue disorders congenital,Cong,N
487,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
488,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
488,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
489,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
489,2,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
489,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
490,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
491,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
492,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
492,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
493,1,Pseudolymphoma,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
494,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
495,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
495,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
495,3,Hypoxic-ischaemic encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
495,4,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
495,5,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
496,1,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
497,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
498,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
499,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
500,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
500,2,Immunoglobulins decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
500,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
501,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
502,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
503,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
504,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
504,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
504,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
505,1,Pseudolymphoma,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
506,1,Visual field defect,Visual field disorders,Vision disorders,Eye,N
507,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
507,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
508,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
508,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
509,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
510,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
510,2,Epileptic aura,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
511,1,Anal atresia,Anorectal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
511,2,Congenital musculoskeletal disorder,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
511,3,Nasal polyps,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
511,4,Renal aplasia,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
512,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
512,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
512,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
513,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
513,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
513,3,Pseudolymphoma,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
514,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
514,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
515,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
515,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
516,1,Pseudolymphoma,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
517,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
518,1,Limb reduction defect,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
519,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
519,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
520,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
520,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
521,1,Spina bifida,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
522,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
523,1,Pseudolymphoma,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
524,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
525,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
526,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
527,1,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
527,2,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
528,1,Pseudolymphoma,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
529,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
530,1,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
530,2,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
531,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
532,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
532,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
532,3,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
533,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
534,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
535,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
536,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
536,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
536,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
537,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
538,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
538,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
539,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
540,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
541,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
542,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
543,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
543,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
543,3,Electroencephalogram abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
544,1,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
544,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
544,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
544,4,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
545,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
545,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
545,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
546,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
546,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
547,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
548,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
549,1,Cerebral atrophy,Structural brain disorders NEC,Structural brain disorders,Nerv,N
549,2,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
549,3,Osteomalacia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
550,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
550,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
550,3,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
550,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
550,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
550,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
550,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
551,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
551,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
552,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
553,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
553,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
554,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
554,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
555,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
556,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
557,1,Congenital musculoskeletal disorder of limbs,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
558,1,Gastrointestinal malformation,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
558,2,Pulmonary valve stenosis,Pulmonary valvular disorders,Cardiac valve disorders,Card,N
559,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
559,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
559,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
560,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
561,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
561,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
562,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
562,2,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
563,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
564,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
564,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
564,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
565,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
566,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
566,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
566,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
566,4,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
566,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
566,6,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
566,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
566,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
567,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
567,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
567,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
568,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
568,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
568,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
568,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
569,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
570,1,Oculogyric crisis,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
571,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
571,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
571,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
571,4,Meningism,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
571,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
571,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
572,1,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
572,2,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
573,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
574,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
574,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
574,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
574,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
575,1,Headache,Headaches NEC,Headaches,Nerv,N
576,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
577,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
578,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
578,2,Metastasis,Metastases to unknown and unspecified sites,Metastases,Neopl,N
579,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
580,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
580,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
580,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
580,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
581,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
582,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
583,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
584,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
585,1,Folate deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
585,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
586,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
587,1,Sideroblastic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
588,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
588,2,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
589,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
590,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
590,2,Food interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
591,1,Hypospadias,Male reproductive tract disorders congenital,Reproductive tract and breast disorders congenital,Cong,N
592,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
593,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
594,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
595,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
596,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
597,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
598,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
598,2,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
599,1,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
600,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
601,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
601,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
602,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
602,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
602,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
603,1,Anaemia folate deficiency,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
603,2,Anaemia macrocytic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
604,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
605,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
606,1,Breast cancer male,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
607,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
608,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
609,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
610,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
610,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
611,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
611,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
612,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
613,1,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
614,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
614,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
614,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
614,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
615,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
615,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
616,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
617,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
617,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
618,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
619,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
619,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
620,1,Myopathy,Myopathies,Muscle disorders,Musc,N
620,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
621,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
622,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
623,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
624,1,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
625,1,Alcohol intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
625,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
626,1,Antinuclear antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
626,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
626,3,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
627,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
627,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
627,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
628,1,Ventricular septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
629,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
630,1,Fibroadenoma of breast,Breast and nipple neoplasms benign,Breast neoplasms benign (incl nipple),Neopl,N
631,1,Fibroadenoma of breast,Breast and nipple neoplasms benign,Breast neoplasms benign (incl nipple),Neopl,N
632,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
633,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
634,1,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
635,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
636,1,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
637,1,Encephalocele,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
638,1,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
639,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
639,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
640,1,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
640,2,Congenital musculoskeletal disorder,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
640,3,Deafness congenital,Hearing disorders congenital,Ear and labyrinthine disorders congenital,Cong,N
641,1,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
641,2,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
642,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
643,1,Cerebellar syndrome,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
644,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
645,1,Anencephaly,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
646,1,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
647,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
648,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
649,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
650,1,Abortion,Abortions not specified as induced or spontaneous,Abortions and stillbirth,Preg,N
651,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
651,2,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
652,1,Macrocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
653,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
653,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
654,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
655,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
655,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
656,1,Pleurisy,Pleural infections and inflammations,Pleural disorders,Resp,N
657,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
658,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
658,2,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
658,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
658,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
658,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
659,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
660,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
661,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
661,2,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
662,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
662,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
662,3,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,Y
662,4,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
663,1,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
663,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
663,3,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
663,4,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
664,1,Histiocytosis,Histiocytoses,Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
665,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
665,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
666,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
666,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
666,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
667,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
668,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
669,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
670,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
671,1,Congenital musculoskeletal disorder,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
671,2,Congenital musculoskeletal disorder of spine,Musculoskeletal and connective tissue disorders of spine congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
671,3,Multiple congenital abnormalities,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
671,4,Tracheo-oesophageal fistula,Laryngeal and tracheal disorders congenital,Respiratory disorders congenital,Cong,N
672,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
673,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
674,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
675,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
675,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
676,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
677,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
678,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
679,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
680,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,Y
681,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
681,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
681,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
681,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
681,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
682,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
683,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
684,1,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
685,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
685,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
686,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
687,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
687,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
687,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
688,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
688,2,Peripheral artery thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
689,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
689,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
690,1,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
690,2,Oculogyric crisis,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
690,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
691,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
692,1,Pseudolymphoma,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
693,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
693,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
693,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
694,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
695,1,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
695,2,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
695,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
695,4,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
696,1,Cerebral atrophy,Structural brain disorders NEC,Structural brain disorders,Nerv,N
696,2,Drug withdrawal convulsions,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
696,3,Optic atrophy,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
697,1,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
698,1,Cerebellar syndrome,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
698,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
699,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
699,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
699,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
699,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
700,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
701,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
702,1,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
702,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
702,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
703,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
703,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
704,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
705,1,Clonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
705,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
705,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
705,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
705,5,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
705,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
705,7,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
706,1,Bruxism,Stereotypies and automatisms,Changes in physical activity,Psych,N
707,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
707,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
708,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
708,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
708,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
709,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
709,2,Thyroxine decreased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
710,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
711,1,Hypospadias,Male reproductive tract disorders congenital,Reproductive tract and breast disorders congenital,Cong,N
711,2,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
712,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,Y
713,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
714,1,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
714,2,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
715,1,Choreoathetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
716,1,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
717,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
718,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
719,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
720,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
720,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
720,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
720,4,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
721,1,Dwarfism,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
721,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
722,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
723,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
724,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
725,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
725,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
725,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
726,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
726,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
726,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
726,4,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,Y
727,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
727,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
728,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
728,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
729,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
729,2,Breast abscess,Breast infections,Infections - pathogen unspecified,Infec,N
729,3,Hypospadias,Male reproductive tract disorders congenital,Reproductive tract and breast disorders congenital,Cong,N
730,1,Headache,Headaches NEC,Headaches,Nerv,N
730,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
730,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
730,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
730,5,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
731,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
731,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
732,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
732,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
733,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
734,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
734,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
735,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
736,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
737,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
738,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
739,1,Cerebellar syndrome,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
739,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
740,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
741,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
741,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
741,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
741,4,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
742,1,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
743,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
744,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
745,1,Pleurisy,Pleural infections and inflammations,Pleural disorders,Resp,N
746,1,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
746,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
747,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
747,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
748,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
749,1,Anorectal disorder,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
750,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
751,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
751,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
752,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
752,2,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
753,1,Congenital musculoskeletal disorder of limbs,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
753,2,Hypospadias,Male reproductive tract disorders congenital,Reproductive tract and breast disorders congenital,Cong,N
754,1,Hypospadias,Male reproductive tract disorders congenital,Reproductive tract and breast disorders congenital,Cong,N
755,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
756,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
757,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
758,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
758,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
758,3,Tongue oedema,Tongue signs and symptoms,Tongue conditions,Gastr,N
759,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
760,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
761,1,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
762,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
763,1,Antinuclear antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
763,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
763,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
764,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
764,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
765,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
765,2,Myeloid leukaemia,Leukaemias myeloid NEC,Leukaemias,Neopl,Y
766,1,Folate deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
766,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
767,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
767,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
767,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
767,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
768,1,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
768,2,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
769,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
770,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
771,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
771,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
772,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
773,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
773,2,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
773,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
773,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
773,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
773,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
774,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
775,1,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
776,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
776,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
777,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
778,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
778,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
778,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
778,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
778,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
779,1,Pseudolymphoma,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
780,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
780,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
781,1,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
782,1,Osteomalacia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
782,2,Pathological fracture,Fractures NEC,Fractures,Musc,N
783,1,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
784,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
785,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
785,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
785,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
786,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
786,2,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
787,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
788,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
788,2,Leukaemoid reaction,Leukocytoses NEC,White blood cell disorders,Blood,N
789,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
790,1,Marrow hyperplasia,Haematologic neoplasms NEC,Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
791,1,Alcohol poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
791,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
791,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
791,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
792,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
793,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
793,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
794,1,Immunodeficiency common variable,Primary immunodeficiency syndromes,Immunodeficiency syndromes,Immun,N
794,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
795,1,Spina bifida,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
796,1,Spina bifida,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
797,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
798,1,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
799,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
800,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
801,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
802,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
803,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
803,2,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
804,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
805,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
806,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
806,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
806,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
806,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
806,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
807,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
807,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
807,3,Headache,Headaches NEC,Headaches,Nerv,N
808,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
809,1,Dupuytren's contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
810,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
810,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
810,3,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
810,4,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
810,5,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
811,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
811,2,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
811,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
811,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
811,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
811,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
812,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
812,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
812,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
813,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
814,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
815,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
815,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
816,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
816,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
816,3,Headache,Headaches NEC,Headaches,Nerv,N
817,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
817,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
817,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
817,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
818,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
819,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
820,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
821,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
821,2,Lymphocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
822,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
823,1,Superficial vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
824,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
825,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
826,1,Chorea,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
827,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
828,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
828,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
828,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
828,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
829,1,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
829,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
829,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
830,1,Nodal rhythm,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
831,1,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
832,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
833,1,Immunoglobulins abnormal,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
833,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
834,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
835,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
835,2,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
835,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
836,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
837,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
838,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
839,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
840,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
841,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
841,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
842,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
842,2,Pregnancy with contraceptive device,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
843,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
843,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
843,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
843,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
844,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
845,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
846,1,Immunoglobulins abnormal,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
847,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
848,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
849,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
849,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
850,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
850,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
851,1,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
852,1,Dupuytren's contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
853,1,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
854,1,Dupuytren's contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
855,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
855,2,Rash follicular,Pustular conditions,Epidermal and dermal conditions,Skin,N
855,3,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
856,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
856,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
857,1,Enteritis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
858,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
858,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
859,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
860,1,Multiple congenital abnormalities,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
861,1,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
862,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
862,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
863,1,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
864,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
865,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
866,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
867,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
867,2,Headache,Headaches NEC,Headaches,Nerv,N
867,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
867,4,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
868,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
869,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
869,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
869,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
869,4,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
870,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
871,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
872,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
872,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
872,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
872,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
872,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
873,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
873,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
873,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
873,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
874,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
874,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
874,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
874,4,Pseudolymphoma,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,Y
875,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
875,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
876,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
876,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
876,3,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
877,1,Cerebellar syndrome,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
878,1,Depersonalisation/derealisation disorder,Dissociative states,Dissociative disorders,Psych,N
878,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
878,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
879,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
880,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
880,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
881,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
881,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
881,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
881,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
882,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
883,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
884,1,Cerebellar syndrome,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
884,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
884,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
884,4,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
885,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
886,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
887,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
888,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
888,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
889,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
889,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
890,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
890,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
890,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
891,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
892,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
892,2,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
892,3,Pseudolymphoma,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
893,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
894,1,Headache,Headaches NEC,Headaches,Nerv,N
894,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
894,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
895,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
895,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
895,3,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
896,1,Cryptorchism,Male reproductive tract disorders congenital,Reproductive tract and breast disorders congenital,Cong,N
896,2,Hernia congenital,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
897,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
898,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
899,1,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
899,2,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
899,3,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
899,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
899,5,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
900,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
900,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
901,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
901,2,Ecchymosis,Purpura and related conditions,Skin vascular abnormalities,Skin,N
902,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
902,2,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
903,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
903,2,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
904,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
905,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
906,1,Parotitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
906,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
906,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
907,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
907,2,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
908,1,Autism spectrum disorder,Pervasive developmental disorders NEC,Developmental disorders NEC,Psych,N
909,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
910,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
911,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
911,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
912,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
912,2,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
912,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
913,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
913,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
913,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
913,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
913,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
914,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
914,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
914,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
915,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
915,2,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
915,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
916,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
916,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
917,1,Cerebral atrophy,Structural brain disorders NEC,Structural brain disorders,Nerv,N
918,1,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
919,1,Metastasis,Metastases to unknown and unspecified sites,Metastases,Neopl,N
919,2,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
919,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
919,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
920,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
920,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
921,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
921,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
922,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
922,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
922,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
923,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
924,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
924,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
925,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
925,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
925,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
926,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
927,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
927,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
927,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
927,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
927,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
927,6,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
927,7,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
928,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
929,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
929,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
930,1,Congenital hydrocephalus,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
931,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
932,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
933,1,Osteomalacia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
934,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
934,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
935,1,Developmental glaucoma,Anterior and posterior chamber disorders congenital,Eye disorders congenital,Cong,N
936,1,Multiple congenital abnormalities,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
937,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
937,2,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
937,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
938,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
938,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
939,1,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
940,1,Choreoathetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
941,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
942,1,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
942,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
943,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
943,2,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
944,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
944,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
945,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
945,2,Folate deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
945,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
945,4,Macrocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
945,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
946,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
946,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
946,3,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
946,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
946,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
947,1,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
947,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
948,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
948,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
949,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
949,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
949,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
950,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
950,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
951,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
952,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
953,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
953,2,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
954,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
954,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
955,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
956,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
957,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
957,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
957,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
958,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
958,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
959,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
959,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
959,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
960,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
960,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
960,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
960,4,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
961,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
961,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
961,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
961,4,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
962,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
963,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
964,1,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
965,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
965,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
966,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
966,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
967,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
968,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
969,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
970,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
971,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
972,1,Food interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
972,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
973,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
974,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
974,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
974,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
975,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
976,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
977,1,Anticonvulsant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
977,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
977,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
977,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
977,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
978,1,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
979,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
980,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
980,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
981,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
982,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
982,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
982,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
983,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
983,2,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
984,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
984,2,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
984,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
985,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
986,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
986,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
987,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
988,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
989,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
990,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
990,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
990,3,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
991,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
991,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
991,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
991,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
991,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
991,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
991,7,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
991,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
991,9,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
991,10,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
991,11,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
991,12,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
991,13,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
991,14,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
991,15,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
992,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
993,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
993,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
994,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
995,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
996,1,Chloasma,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
997,1,Necrosis ischaemic,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
998,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
998,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
998,3,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
999,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
999,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1000,1,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
1000,2,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
1001,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
1001,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1001,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1001,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1001,5,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
1001,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1001,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1002,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1002,2,Lip ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1002,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1002,4,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1002,5,Toxic skin eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1003,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1004,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1004,2,Toxic skin eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1005,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1005,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1005,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1006,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1006,2,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
1007,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1007,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1008,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1008,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1009,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1009,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1009,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1009,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1010,1,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1010,2,Loss of control of legs,Gait disturbances,General system disorders NEC,Genrl,N
1010,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1011,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1011,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1012,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1012,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1012,3,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1013,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1014,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1014,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1015,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1015,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1015,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1015,4,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1016,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1017,1,Drug level fluctuating,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1017,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1018,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1018,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1018,3,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
1018,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1019,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
1020,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1020,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1021,1,Dupuytren's contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1022,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1022,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1023,1,Hypospadias,Male reproductive tract disorders congenital,Reproductive tract and breast disorders congenital,Cong,N
1024,1,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1024,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1025,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1025,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1026,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1026,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1026,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1026,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1027,1,Cerebellar syndrome,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1028,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1029,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1030,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1031,1,Acanthosis,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
1031,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
1031,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1031,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1031,5,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1031,6,Pharyngeal ulceration,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1031,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1031,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1032,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1032,2,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1032,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1033,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1033,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1033,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1034,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
1035,1,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1035,2,Protein total decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1035,3,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1036,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1036,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1036,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1037,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1038,1,Anticonvulsant drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1038,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1039,1,Meningomyelocele,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
1040,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1041,1,Bone marrow disorder,Haematological disorders,Haematological disorders NEC,Blood,N
1041,2,Granuloma,Inflammations,General system disorders NEC,Genrl,N
1041,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1041,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1042,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1043,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1044,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1045,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1045,2,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
1045,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1045,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1045,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1045,6,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1046,1,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
1047,1,Anticonvulsant drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1047,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1048,1,Anticonvulsant drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1048,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1048,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1048,4,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1049,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1050,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1051,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1052,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
1053,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1053,2,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1054,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1055,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1055,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1056,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1057,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1058,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1058,2,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
1058,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1058,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1059,1,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1059,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1059,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1059,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1059,5,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1059,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1060,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1061,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
1062,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1063,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
1063,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1063,3,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1064,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1065,1,Osteomalacia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1066,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1066,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1066,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1067,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1068,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1068,2,Kyphosis,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1068,3,Myopathy,Myopathies,Muscle disorders,Musc,N
1068,4,Neck deformity,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1068,5,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1068,6,Paraparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1068,7,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
1068,8,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
1069,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1070,1,Osteomalacia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1071,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1071,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1072,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
1072,2,Dysmorphism,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
1072,3,Dyspraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1073,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1074,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1075,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1076,1,Nasal dryness,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1076,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1076,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1077,1,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1077,2,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1078,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
1079,1,Superficial vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1080,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1080,2,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1081,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1082,1,Disinhibition,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1083,1,Vascular compression,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1084,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1084,2,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
1084,3,Klebsiella sepsis,Klebsiella infections,Bacterial infectious disorders,Infec,N
1084,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1084,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1084,6,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1085,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1085,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1086,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1087,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1088,1,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1089,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1089,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1089,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1089,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1090,1,Foetal anticonvulsant syndrome,Chemically-induced congenital syndromes,Congenital and hereditary disorders NEC,Cong,N
1091,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1092,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1092,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1093,1,Foetal anticonvulsant syndrome,Chemically-induced congenital syndromes,Congenital and hereditary disorders NEC,Cong,N
1094,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1094,2,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1094,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1094,4,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1095,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1096,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1097,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1097,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1098,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1098,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1098,3,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
1099,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1100,1,Anticonvulsant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1100,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1100,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1101,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1101,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1102,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1103,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1103,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1103,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1104,1,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
1105,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1106,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1107,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1108,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1108,2,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1109,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1109,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
1110,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1110,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1110,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1111,1,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1111,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1111,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1111,4,Dyspraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1112,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1112,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1113,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1113,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1114,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1115,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1115,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1115,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1115,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1115,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1116,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1116,2,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1116,3,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1116,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1116,5,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1116,6,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1116,7,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1116,8,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1116,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1116,10,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1117,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1117,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1117,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1117,4,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1117,5,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
1117,6,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1117,7,Headache,Headaches NEC,Headaches,Nerv,N
1117,8,Tongue disorder,Tongue disorders,Tongue conditions,Gastr,N
1118,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1119,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1120,1,Anticonvulsant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1120,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1120,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1121,1,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,Y
1121,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1122,1,Blood folate decreased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1122,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1123,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1123,2,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1124,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1124,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1125,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1125,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1125,3,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1125,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1125,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1126,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
1127,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1127,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1127,3,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1127,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1127,5,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1127,6,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1127,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1128,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1128,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1128,3,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1128,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1128,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1128,6,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
1128,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1128,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1129,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1129,2,Spinal compression fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
1130,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1130,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1130,3,Head titubation,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1130,4,Headache,Headaches NEC,Headaches,Nerv,N
1130,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1131,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1131,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1131,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1131,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1131,5,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1132,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1132,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1133,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1134,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1134,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1135,1,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1136,1,Congenital vesicoureteric reflux,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
1137,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1137,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1137,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1137,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1137,5,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1137,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1138,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
1138,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1138,3,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1139,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1139,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1140,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1140,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
1140,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1140,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1141,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1141,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1141,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1141,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1141,5,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1142,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1142,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1143,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1143,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1144,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1145,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1146,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1146,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1147,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1147,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1147,3,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1148,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1148,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1148,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1149,1,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
1150,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1150,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1150,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1151,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
1152,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1152,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1152,3,Mucocutaneous ulceration,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1152,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1152,5,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1152,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1153,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1153,2,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1154,1,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1155,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1155,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1156,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1157,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1157,2,Myopathy,Myopathies,Muscle disorders,Musc,N
1157,3,Osteomalacia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1158,1,Klinefelter's syndrome,Sex chromosomal abnormalities,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
1159,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1160,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1160,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1160,3,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1161,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1162,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
1163,1,Systemic lupus erythematosus rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1164,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
1164,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1165,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1165,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1165,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1165,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1166,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1166,2,Headache,Headaches NEC,Headaches,Nerv,N
1166,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1166,4,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1166,5,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1166,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1167,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,Y
1168,1,Infertility male,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
1168,2,Oligospermia,Spermatogenesis and semen disorders,Sexual function and fertility disorders,Repro,N
1169,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1169,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1169,3,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1170,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
1171,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1172,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1172,2,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1172,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1172,4,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1173,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1174,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1174,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1175,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1176,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1176,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1177,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1177,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1178,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,Y
1179,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1179,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,Y
1180,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1180,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1181,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1181,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1181,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1181,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1181,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1182,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1183,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1183,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1183,3,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1184,1,Cerebellar ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1184,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1184,3,Dysdiadochokinesis,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1184,4,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1184,5,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1184,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1185,1,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1185,2,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1186,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1187,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1187,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1187,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1187,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1188,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1188,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1189,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1189,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1189,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1189,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1189,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1189,6,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1189,7,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1189,8,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1189,9,Vitamin B12 deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
1190,1,Anticonvulsant drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1190,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1190,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1190,4,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1191,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1192,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1193,1,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
1193,2,Tooth malformation,Dental developmental disorders and anomalies,Dental and gingival conditions,Gastr,N
1194,1,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
1194,2,Tooth malformation,Dental developmental disorders and anomalies,Dental and gingival conditions,Gastr,N
1195,1,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1196,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1196,2,Craniocerebral injury,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1196,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1196,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1196,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1197,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1197,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1197,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1197,4,Plasmodium falciparum infection,Plasmodia infections,Protozoal infectious disorders,Infec,N
1197,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1197,6,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1197,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1197,8,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1197,9,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1198,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1199,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1199,2,Catarrh,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1199,3,Rectal discharge,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
1200,1,Drug level,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1200,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1201,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1201,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1202,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1202,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1202,3,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1203,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1204,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1204,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1205,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1205,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1206,1,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1206,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1207,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1208,1,Anticonvulsant drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1208,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1209,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1209,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1210,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1211,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1211,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1211,3,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1211,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1211,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1211,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1212,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1212,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1213,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1213,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1214,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1214,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1215,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1215,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1215,3,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
1216,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1216,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1217,1,Polyp,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1218,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1218,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1218,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1218,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1218,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1218,6,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1218,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1219,1,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1219,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1220,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1220,2,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1221,1,Drug level fluctuating,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1221,2,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
1221,3,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1222,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1222,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1222,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1222,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1222,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1223,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1223,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1223,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1223,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1223,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1224,1,Bedridden,Disability issues,Lifestyle issues,SocCi,N
1224,2,Communication disorder,Communications disorders,Communication disorders and disturbances,Psych,N
1224,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1224,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1225,1,Body height decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1225,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1225,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1225,4,Multiple fractures,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
1225,5,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1225,6,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1226,1,Anticonvulsant drug level abnormal,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1226,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1227,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1228,1,Anticonvulsant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1228,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1229,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1229,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1230,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1230,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1231,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1231,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1232,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1232,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1233,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1233,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1233,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1234,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1234,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1234,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1235,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1235,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1236,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1237,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1237,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1237,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1238,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1238,2,Infectious mononucleosis,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1238,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1238,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1238,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1239,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1239,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1239,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1240,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1240,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1241,1,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1241,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1241,3,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1241,4,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1241,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1241,6,Staphylococcal scalded skin syndrome,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1242,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1243,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1244,1,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1244,2,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1244,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1244,4,Mental status changes,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1244,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1244,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1244,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1245,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1245,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1246,1,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1246,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1247,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1247,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1248,1,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1248,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1248,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1249,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1250,1,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
1251,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1251,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1252,1,Orthopaedic procedure,Bone therapeutic procedures NEC,Bone and joint therapeutic procedures,Surg,N
1253,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1253,2,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1254,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1254,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1254,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1254,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1255,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1256,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1256,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1257,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1257,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1257,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1257,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1257,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1257,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1258,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1258,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1259,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1259,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1260,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1261,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1262,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1262,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1263,1,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1263,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1263,3,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1263,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1263,5,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1264,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1264,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1264,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1264,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1265,1,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1266,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1266,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1267,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1267,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1268,1,Folate deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
1269,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1269,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1269,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1270,1,Anticonvulsant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1271,1,Injection site extravasation,Injection site reactions,Administration site reactions,Genrl,N
1272,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1272,2,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1272,3,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1272,4,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1272,5,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
1272,6,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1272,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1272,8,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1272,9,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1272,10,Transaminases abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1273,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1274,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1274,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1274,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1275,1,Anticonvulsant drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1275,2,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
1275,3,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
1276,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
1276,2,Blood phosphorus increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1276,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1276,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1276,5,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1276,6,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1276,7,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1276,8,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1276,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1276,10,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1276,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1277,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1278,1,Palmar erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1278,2,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1279,1,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1279,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
1279,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1280,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1281,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1281,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1281,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1281,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1281,5,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1281,6,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1281,7,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1281,8,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1282,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1282,2,Blood urea decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1282,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1282,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1283,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1283,2,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1284,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1284,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1285,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1285,2,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1286,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1286,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1286,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1286,4,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1286,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1286,6,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1286,7,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1286,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1286,9,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1286,10,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1286,11,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1286,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1286,13,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1286,14,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1287,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1288,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1289,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1290,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1290,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1290,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1290,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1290,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1291,1,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1291,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1291,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1291,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1292,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1293,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1294,1,Asphyxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,Y
1294,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1295,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1295,2,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1295,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1296,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1297,1,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1298,1,Brain compression,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,Y
1298,2,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1298,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1298,4,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1298,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1298,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1299,1,Connective tissue disorder,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
1300,1,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1300,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1301,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1301,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
1302,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1303,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1303,2,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1303,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1304,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1305,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1305,2,Odynophagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1305,3,Osteoporotic fracture,Fractures NEC,Fractures,Musc,N
1306,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1306,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1306,3,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1307,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1307,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1307,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1308,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
1309,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1309,2,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1310,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1310,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1310,3,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1310,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1311,1,Anticonvulsant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1311,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1312,1,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1312,2,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1312,3,Breast disorder,Breast disorders NEC,Breast disorders,Repro,N
1312,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1312,5,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1312,6,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1312,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1312,8,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1312,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1312,10,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1313,1,Abnormal faeces,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1313,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1313,3,Autism spectrum disorder,Pervasive developmental disorders NEC,Developmental disorders NEC,Psych,N
1313,4,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1313,5,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1313,6,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1313,7,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1313,8,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1313,9,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1313,10,Cortical dysplasia,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
1313,11,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1313,12,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1313,13,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1313,14,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1313,15,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1313,16,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1313,17,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1313,18,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1313,19,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1313,20,Lactose intolerance,Sugar intolerance (excl glucose intolerance),Food intolerance syndromes,Metab,N
1313,21,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1313,22,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1313,23,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1313,24,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1313,25,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1313,26,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1313,27,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1313,28,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1313,29,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1313,30,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1313,31,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1313,32,Vaginal infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
1313,33,Vomiting projectile,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1314,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1315,1,Anaemia macrocytic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1315,2,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1315,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1315,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1315,5,Dysmetria,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1315,6,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1315,7,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1315,8,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1315,9,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1315,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1315,11,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1316,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1316,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1316,3,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1316,4,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1316,5,Dysdiadochokinesis,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1316,6,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1316,7,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1316,8,Past-pointing,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1316,9,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1316,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1317,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1317,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1317,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1317,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1317,5,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1317,6,Mean cell volume increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1317,7,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1317,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1318,1,Anticonvulsant drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1318,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1318,3,Cerebellar syndrome,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1318,4,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1318,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1318,6,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1318,7,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1319,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1319,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1319,3,Cerebellar syndrome,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1319,4,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1319,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1319,6,Dysdiadochokinesis,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1319,7,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1319,8,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1319,9,Past-pointing,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1319,10,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1319,11,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1319,12,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1320,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1320,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1321,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1321,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1322,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1322,2,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1323,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1323,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1323,3,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1324,1,Anaemia macrocytic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1324,2,Cerebellar syndrome,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1324,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1324,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1324,5,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1324,6,Dysmetria,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1324,7,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1324,8,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1324,9,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1324,10,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1324,11,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1324,12,Thrombocytosis,Thrombocytoses,Platelet disorders,Blood,N
1324,13,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1325,1,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1325,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1325,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1326,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1327,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1328,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,Y
1329,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1330,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1330,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1330,3,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1330,4,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
1331,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1331,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1331,3,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1332,1,Gastrostomy,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
1333,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1333,2,Anticonvulsant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1333,3,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1333,4,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
1333,5,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
1333,6,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1333,7,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1333,8,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1333,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1334,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1334,2,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1334,3,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1334,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1335,1,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
1336,1,Osteoporotic fracture,Fractures NEC,Fractures,Musc,N
1337,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1337,2,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
1338,1,Blood testosterone decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
1338,2,Circadian rhythm sleep disorder,Disturbances in sleep phase rhythm,Sleep disturbances (incl subtypes),Nerv,N
1338,3,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
1339,1,Osteoporosis postmenopausal,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1340,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1340,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1340,3,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1340,4,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1340,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1340,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1340,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1340,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1341,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1341,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1342,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1342,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1343,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1343,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1344,1,Cardiac septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
1344,2,Dysmorphism,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
1344,3,Foetal anticonvulsant syndrome,Chemically-induced congenital syndromes,Congenital and hereditary disorders NEC,Cong,N
1344,4,Haemangioma,Cardiovascular neoplasms benign,Miscellaneous and site unspecified neoplasms benign,Neopl,N
1344,5,Speech disorder developmental,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1345,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1345,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1346,1,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
1347,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1347,2,Medical diet,Dietary and nutritional therapies,Therapeutic procedures and supportive care NEC,Surg,N
1347,3,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1348,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1348,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1348,3,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1348,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1348,5,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1348,6,Face oedema,Oedema NEC,General system disorders NEC,Genrl,Y
1348,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1348,8,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1348,9,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1349,1,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1349,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1349,3,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
1349,4,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1349,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1349,6,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1349,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1350,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1350,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1350,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1350,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1350,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1351,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1351,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1351,3,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1352,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1353,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1353,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1353,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1354,1,Anticonvulsant drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1355,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1356,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1357,1,Androgen deficiency,Male gonadal function disorders,Endocrine disorders of gonadal function,Endo,N
1357,2,Body temperature fluctuation,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1357,3,Circadian rhythm sleep disorder,Disturbances in sleep phase rhythm,Sleep disturbances (incl subtypes),Nerv,N
1357,4,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
1358,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1359,1,Anticonvulsant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1359,2,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1359,3,Gastrostomy,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
1360,1,Anticonvulsant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1360,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1361,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
1361,2,Gastrostomy,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
1362,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1362,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1362,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1362,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1363,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
1364,1,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1364,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1364,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1364,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1364,5,Hostility,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1364,6,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1364,7,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1364,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1365,1,Purple glove syndrome,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1366,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1367,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1367,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1367,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1368,1,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1369,1,Ileostomy,Small intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
1369,2,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1370,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1371,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1371,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1372,1,Motor neurone disease,Motor neurone diseases,Neuromuscular disorders,Nerv,N
1372,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1373,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1374,1,Migraine,Migraine headaches,Headaches,Nerv,N
1374,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1375,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1375,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1375,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1375,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1375,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1375,6,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1375,7,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
1375,8,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1375,9,Optic nerve disorder,Visual pathway disorders,Vision disorders,Eye,N
1375,10,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1375,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1376,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1376,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1377,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1378,1,Anticonvulsant drug level,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1378,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1378,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1379,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1379,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1379,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1380,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1380,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1380,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1381,1,Priapism,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1381,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1382,1,Priapism,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1383,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1384,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1385,1,Autism spectrum disorder,Pervasive developmental disorders NEC,Developmental disorders NEC,Psych,N
1386,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1386,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1387,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1387,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1388,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
1389,1,Anticonvulsant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1389,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1390,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1390,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1390,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1391,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1391,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1392,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1393,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1394,1,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1394,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1394,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1395,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1396,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1396,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1396,3,Cytokine storm,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1396,4,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1396,5,Delirium,Deliria,Deliria (incl confusion),Psych,N
1396,6,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1396,7,Impetigo,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1396,8,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1397,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1397,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
1398,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1398,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1398,3,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1399,1,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1399,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,Y
1400,1,Purple glove syndrome,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1401,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1402,1,Purple glove syndrome,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1403,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1403,2,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1404,1,Congenital vesicoureteric reflux,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
1405,1,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1405,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1406,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1406,2,Headache,Headaches NEC,Headaches,Nerv,N
1406,3,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
1406,4,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1406,5,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
1406,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1406,7,Temporal lobe epilepsy,Partial complex seizures,Seizures (incl subtypes),Nerv,N
1407,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1407,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1408,1,Deformity,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1408,2,Tooth erosion,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1409,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1410,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1411,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1411,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1411,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1412,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1413,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1414,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1414,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1414,3,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1415,1,Ventricular septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
1416,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1416,2,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1417,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1417,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
1417,3,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1417,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1418,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1419,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1419,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1420,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1420,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1421,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1421,2,Brain herniation,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1421,3,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1421,4,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1421,5,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
1421,6,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1421,7,Idiosyncratic drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1421,8,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1422,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1423,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
1424,1,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1424,2,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1424,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1425,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1426,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1426,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1426,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1426,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1426,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1426,6,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1426,7,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1426,8,Headache,Headaches NEC,Headaches,Nerv,N
1426,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1426,10,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1426,11,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1426,12,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1426,13,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1426,14,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1427,1,Testicular oedema,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
1428,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1429,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1429,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1430,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1430,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1430,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1431,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1432,1,Cerebellar ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1432,2,Cerebellar syndrome,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1432,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1432,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1432,5,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1432,6,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1432,7,Loss of control of legs,Gait disturbances,General system disorders NEC,Genrl,N
1432,8,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1432,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1432,10,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1432,11,Thought blocking,Thinking disturbances,Disturbances in thinking and perception,Psych,N
1433,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1434,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1435,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1435,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1435,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1435,4,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
1435,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1435,6,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1435,7,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1435,8,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1436,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1436,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1437,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1438,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1438,2,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1439,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1439,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1439,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1439,4,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1440,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1440,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1441,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1441,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1442,1,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1443,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1444,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1444,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1444,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1445,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1445,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1446,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1446,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1446,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1446,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1446,5,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1447,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1447,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1448,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1449,1,Anticonvulsant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1449,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1450,1,Androgen deficiency,Male gonadal function disorders,Endocrine disorders of gonadal function,Endo,N
1450,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1450,3,Circadian rhythm sleep disorder,Disturbances in sleep phase rhythm,Sleep disturbances (incl subtypes),Nerv,N
1450,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1450,5,Hypothalamo-pituitary disorder,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
1450,6,Sperm concentration zero,Fertility analyses and other reproductive function procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
1450,7,Temperature regulation disorder,Body temperature altered,Body temperature conditions,Genrl,N
1451,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1451,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1451,3,Bone loss,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1451,4,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1451,5,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1451,6,Chronic kidney disease-mineral and bone disorder,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1451,7,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1451,8,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1451,9,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1451,10,Hyperparathyroidism secondary,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1451,11,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1451,12,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1451,13,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1451,14,Osteomalacia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1451,15,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1451,16,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1451,17,Vitamin D deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
1451,18,Wheelchair user,Disability issues,Lifestyle issues,SocCi,N
1452,1,Asphyxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,Y
1452,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1453,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1453,2,Terminal state,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1454,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1455,1,Priapism,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1456,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1456,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1456,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1456,4,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1456,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1457,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1457,2,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1458,1,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1458,2,Antidiuretic hormone abnormality,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1458,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1458,4,Biliary obstruction,Obstructive bile duct disorders (excl neoplasms),Bile duct disorders,Hepat,N
1458,5,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1458,6,Cholangitis,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
1458,7,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1458,8,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1458,9,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1458,10,Hepatic enzyme abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1458,11,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1458,12,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1458,13,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1458,14,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1458,15,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1458,16,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1458,17,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1459,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1459,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1459,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1459,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1460,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1460,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1460,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1460,4,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1461,1,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1461,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1461,3,Drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1461,4,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,Y
1461,5,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1461,6,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1461,7,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1462,1,Enlarged clitoris,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1462,2,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1462,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1462,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1463,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1464,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1464,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1464,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1464,4,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
1464,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1465,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1465,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1465,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1465,4,Pyroglutamate increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1465,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1465,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1465,7,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1466,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1467,1,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1467,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1467,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1468,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1469,1,Akinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1469,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1469,3,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1469,4,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1469,5,Cerebral atrophy,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1469,6,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1469,7,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1469,8,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
1469,9,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1469,10,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1469,11,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1469,12,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1469,13,Learning disability,Learning disorders,Cognitive and attention disorders and disturbances,Psych,N
1469,14,Learning disorder,Learning disorders,Cognitive and attention disorders and disturbances,Psych,N
1469,15,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1469,16,Mycoplasma infection,Mycoplasma infections,Mycoplasmal infectious disorders,Infec,N
1469,17,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1469,18,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1470,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1470,2,Catheter site related reaction,Implant and catheter site reactions,Administration site reactions,Genrl,N
1470,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1471,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
1471,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1472,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1472,2,Blood parathyroid hormone increased,Parathyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
1472,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1472,4,Osteomalacia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1472,5,Thyroid hormones increased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
1472,6,Vitamin D increased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1473,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1474,1,Purple glove syndrome,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1475,1,Anticonvulsant drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1475,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1475,3,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1475,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1476,1,Anticonvulsant drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1476,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1477,1,Purple glove syndrome,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1478,1,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,Y
1479,1,Drug level fluctuating,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1479,2,Food interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1480,1,Blood homocysteine increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
1480,2,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
1480,3,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1480,4,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1480,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1480,6,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1481,1,Alcohol poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1481,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1482,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1482,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1482,3,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1482,4,Myoclonic epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1482,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1483,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1483,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1483,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1484,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1484,2,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1484,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1484,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1484,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1485,1,Purple glove syndrome,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1486,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1487,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1488,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1488,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
1488,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1488,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1488,5,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1488,6,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1489,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1490,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,Y
1491,1,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1491,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1491,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1492,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1492,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1492,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1493,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1493,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1493,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1494,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1494,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1494,3,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1495,1,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1496,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1497,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1497,2,Purple glove syndrome,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1498,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1499,1,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
1500,1,Congenital musculoskeletal disorder of limbs,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
1501,1,Polydactyly,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
1502,1,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1502,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1502,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1503,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
1503,2,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1503,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1504,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1505,1,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1506,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1507,1,Hyperplasia,Trophic disorders,Tissue disorders NEC,Genrl,N
1508,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1508,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1508,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1508,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1508,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1508,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1509,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1509,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1509,3,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1509,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1509,5,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1510,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1511,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1512,1,Akinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1512,2,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1512,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1512,4,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1512,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1513,1,Corneal deposits,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
1514,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1514,2,Headache,Headaches NEC,Headaches,Nerv,N
1514,3,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1514,4,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1515,1,Neutrophil count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1516,1,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1517,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1517,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1517,3,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
1517,4,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1517,5,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
1517,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1517,7,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1517,8,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1517,9,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1517,10,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1518,1,Anisocoria,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1518,2,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1518,3,Cerebral ischaemia,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1518,4,Conjunctivitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
1518,5,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1518,6,Pulmonary artery stenosis,Vascular pulmonary disorders NEC,Pulmonary vascular disorders,Resp,N
1518,7,Shunt thrombosis,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1518,8,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1519,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1520,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1520,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1520,3,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1520,4,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1521,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1521,2,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
1522,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1522,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1523,1,Purple glove syndrome,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1524,1,Glomerulonephritis membranoproliferative,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1524,2,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1525,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1525,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1525,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1526,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
1527,1,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1527,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1528,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1528,2,Refusal of treatment by patient,Social issues NEC,Lifestyle issues,SocCi,N
1528,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1528,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1529,1,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1530,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1531,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1532,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1532,2,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1532,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1532,4,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1533,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1533,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1533,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1533,4,Headache,Headaches NEC,Headaches,Nerv,N
1533,5,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
1533,6,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
1533,7,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1533,8,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1533,9,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1533,10,Vitreous detachment,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1534,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1535,1,Anticonvulsant drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1535,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1535,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1536,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1536,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1536,3,Seizure cluster,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1537,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1537,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1537,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1537,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1537,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1538,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1538,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1538,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1538,4,Haemochromatosis,Iron excess,Iron and trace metal metabolism disorders,Metab,N
1539,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1539,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1539,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1539,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1539,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
1539,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1540,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
1540,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1540,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1541,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1541,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1541,3,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1541,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1542,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1542,2,Dyschromatopsia,Colour blindness (incl acquired),Vision disorders,Eye,N
1542,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1543,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
1544,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1544,2,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1544,3,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1544,4,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1544,5,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
1544,6,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1544,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1544,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1544,9,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1545,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1545,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1546,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1546,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1546,3,Hypoventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1546,4,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1546,5,Respiratory acidosis,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1546,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1547,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1548,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1549,1,Blood pressure systolic decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1549,2,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,Y
1549,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1550,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1550,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1550,3,Headache,Headaches NEC,Headaches,Nerv,N
1550,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1550,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1551,1,Hepatitis toxic,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1551,2,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1552,1,Anticonvulsant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1552,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1552,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1553,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1553,2,Anticonvulsant drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1553,3,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1553,4,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1553,5,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1553,6,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1553,7,Hyporeflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1553,8,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1553,9,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1553,10,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1553,11,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1553,12,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1553,13,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1553,14,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1554,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1554,2,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
1554,3,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1554,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1555,1,Cerebellar syndrome,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1555,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1555,3,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1555,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1555,5,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1555,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1556,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1556,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1556,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1556,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1556,5,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1556,6,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1556,7,Intention tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1556,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1556,9,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1556,10,Past-pointing,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1556,11,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1556,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1557,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1558,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,Y
1558,2,Metastases to meninges,Metastases to specified sites,Metastases,Neopl,N
1558,3,Metastases to meninges,Metastases to specified sites,Metastases,Neopl,N
1558,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1559,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1559,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1559,3,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1559,4,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1559,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1559,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1559,7,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1559,8,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1559,9,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1559,10,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1559,11,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1559,12,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1559,13,Intention tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1559,14,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1559,15,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1559,16,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1559,17,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1559,18,Past-pointing,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1559,19,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1559,20,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1560,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1561,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1562,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1563,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1564,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1564,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1565,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1566,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1566,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1567,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1567,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1567,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1567,4,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1567,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1567,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1567,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1568,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1568,2,Anticonvulsant drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1568,3,Head banging,Stereotypies and automatisms,Changes in physical activity,Psych,N
1569,1,Glioblastoma multiforme,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
1569,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1569,3,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1569,4,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1570,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1571,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1572,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1573,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1573,2,Gingival swelling,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1573,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1573,4,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1574,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1574,2,Headache,Headaches NEC,Headaches,Nerv,N
1574,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1574,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1574,5,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1574,6,Oral pruritus,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1574,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1574,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1574,9,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1574,10,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1575,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1575,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1575,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1576,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1576,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1577,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1577,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1578,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1578,2,Choreoathetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
1578,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1578,4,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1578,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1578,6,Toxic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1578,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1579,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1579,2,Choreoathetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
1579,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1579,4,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1579,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1579,6,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1579,7,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1579,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1579,9,Toxic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1579,10,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1580,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1581,1,Choreoathetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
1581,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1582,1,Clumsiness,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1582,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1582,3,Intellectual disability,Intellectual disabilities,Mental impairment disorders,Nerv,N
1583,1,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1583,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1583,3,Choreoathetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
1583,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1583,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1584,1,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1584,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1584,3,Choreoathetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
1584,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1584,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1584,6,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1584,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1585,1,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1585,2,Choreoathetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
1585,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1585,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1586,1,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1586,2,Choreoathetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
1586,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1586,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1587,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1587,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1588,1,Anticonvulsant drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1588,2,Asterixis,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1588,3,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1588,4,Cerebellar syndrome,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1588,5,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1588,6,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1588,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1589,1,Anticonvulsant drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1589,2,Chorea,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
1589,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1589,4,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1589,5,Early onset primary dystonia,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
1589,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1589,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1590,1,Anticonvulsant drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1590,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1590,3,Chorea,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
1590,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1590,5,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
1590,6,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1590,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1590,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1591,1,Asterixis,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1591,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1591,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1591,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1591,5,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1591,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1591,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1591,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1592,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1592,2,Asterixis,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1592,3,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1592,4,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1592,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1592,6,Headache,Headaches NEC,Headaches,Nerv,N
1592,7,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1592,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1592,9,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1593,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1593,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1593,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1593,4,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1593,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1593,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1593,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1594,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1595,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1595,2,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1595,3,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1596,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1597,1,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1597,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1598,1,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1598,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1599,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1600,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1600,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1601,1,Hyperammonaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
1601,2,Metabolic disorder,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
1602,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1602,2,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1603,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1603,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1604,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1604,2,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
1605,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
1606,1,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1606,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1606,3,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1606,4,Joint dislocation,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
1606,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1606,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1606,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1607,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1607,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1608,1,Asterixis,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1608,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1608,3,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1608,4,Cerebellar ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1608,5,Dupuytren's contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1608,6,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1608,7,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1608,8,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1608,9,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1608,10,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1608,11,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
1608,12,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1608,13,Intention tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1608,14,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1608,15,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1608,16,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1608,17,Spider naevus,Telangiectasia and related conditions,Skin vascular abnormalities,Skin,N
1608,18,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1609,1,Anticonvulsant drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1609,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1609,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1609,4,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1609,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1609,6,Gingival disorder,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1609,7,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1609,8,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1609,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1609,10,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
1609,11,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1609,12,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1610,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
1611,1,Blood ketone body increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
1611,2,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1611,3,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1612,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1613,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1613,2,Dry gangrene,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,Y
1613,3,Peripheral artery thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1614,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1614,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1615,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1615,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1615,3,Intestinal dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1615,4,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1616,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1617,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1617,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1617,3,Purple glove syndrome,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1617,4,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1618,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1618,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1618,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1619,1,Drug level changed,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1619,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1620,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1620,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1620,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1620,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1621,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1621,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1622,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1623,1,Infusion site rash,Infusion site reactions,Administration site reactions,Genrl,N
1623,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1624,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1625,1,Methaemoglobinaemia,Haematological disorders,Haematological disorders NEC,Blood,N
1625,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1626,1,Erythrodermic psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1627,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1628,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1629,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1629,2,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1629,3,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1630,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1630,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1630,3,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1630,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1631,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1632,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1632,2,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1632,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1633,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1633,2,Product deposit,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1633,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1634,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1634,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
1634,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1634,4,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1634,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1634,6,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1635,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1636,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1636,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1636,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1636,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1636,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1637,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1637,2,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
1638,1,Humoral immune defect,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1639,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1639,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1640,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1640,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1641,1,Humoral immune defect,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1642,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1642,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1642,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1643,1,Humoral immune defect,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1644,1,Anticonvulsant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1644,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1644,3,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1645,1,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1646,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1646,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1646,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1647,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1647,2,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1647,3,Spinal compression fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
1648,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1648,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1649,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1650,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1651,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1651,2,Overlap syndrome,Autoimmune disorders NEC,Autoimmune disorders,Immun,N
1651,3,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1652,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1652,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1652,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1653,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1653,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1653,3,Blood testosterone increased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
1653,4,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1653,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1653,6,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1654,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1654,2,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1654,3,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1654,4,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
1654,5,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1654,6,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1654,7,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1654,8,Lymphocyte morphology abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1654,9,Mononucleosis syndrome,Infections NEC,Infections - pathogen unspecified,Infec,N
1654,10,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
1654,11,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1654,12,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1654,13,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1654,14,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1655,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1655,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1656,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1656,2,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1656,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1656,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1656,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1656,6,Traumatic intracranial haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1657,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1657,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,Y
1657,3,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1658,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1658,2,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1658,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1658,4,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1658,5,Granuloma,Inflammations,General system disorders NEC,Genrl,N
1658,6,Left ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
1658,7,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1658,8,Microcytic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1658,9,Overlap syndrome,Autoimmune disorders NEC,Autoimmune disorders,Immun,N
1658,10,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1658,11,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
1658,12,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1658,13,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1659,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1659,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1659,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1660,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1660,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1660,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1661,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1662,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1663,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1663,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1663,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1663,4,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1663,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1663,6,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1663,7,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1664,1,Anticonvulsant drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1664,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1665,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1666,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1667,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1668,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1669,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1670,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1671,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1672,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1673,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1674,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1675,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1676,1,Injection site phlebitis,Injection site reactions,Administration site reactions,Genrl,N
1677,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1678,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1679,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1680,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1680,2,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1681,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1682,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1683,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1684,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1684,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1685,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
1685,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1686,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
1686,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1687,1,Anaemia macrocytic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1687,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1687,3,Thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
1688,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1689,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
1690,1,Neuropsychiatric syndrome,Mental disorders due to a general medical condition NEC,Psychiatric disorders NEC,Psych,N
1691,1,Injection site phlebitis,Injection site reactions,Administration site reactions,Genrl,N
1692,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1692,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1692,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1692,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1693,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
1693,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1693,3,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1694,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1694,2,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1694,3,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1694,4,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1694,5,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1694,6,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1694,7,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1694,8,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1694,9,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1694,10,Headache,Headaches NEC,Headaches,Nerv,N
1694,11,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1694,12,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1694,13,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1694,14,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1694,15,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1694,16,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1694,17,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1694,18,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1694,19,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1694,20,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1694,21,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1694,22,Urine odour abnormal,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1694,23,VIth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1695,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1696,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1697,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1697,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1698,1,Methaemoglobinaemia,Haematological disorders,Haematological disorders NEC,Blood,N
1699,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1699,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1699,3,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1699,4,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,Y
1699,5,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1700,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1700,2,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
1700,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1700,4,Product preparation error,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1700,5,Soft tissue injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1701,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1701,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1701,3,Headache,Headaches NEC,Headaches,Nerv,N
1701,4,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1701,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1702,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1702,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1702,3,Headache,Headaches NEC,Headaches,Nerv,N
1702,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1702,5,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1702,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1703,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1704,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1705,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1706,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1706,2,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1706,3,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1706,4,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1706,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1706,6,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1707,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1707,2,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1708,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1709,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1709,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1709,3,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1710,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1711,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
1711,2,Infusion site warmth,Infusion site reactions,Administration site reactions,Genrl,N
1712,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1712,2,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1712,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1713,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1713,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1714,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1714,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1714,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1714,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1715,1,Anticonvulsant drug level abnormal,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1715,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1715,3,Product monitoring error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1715,4,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1716,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1716,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1717,1,Purple glove syndrome,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1718,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1719,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1719,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1719,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1719,4,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1720,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1720,2,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1720,3,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1721,1,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
1721,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1721,3,Satoyoshi syndrome,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1722,1,Macule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1722,2,Mucosal erosion,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1722,3,Oral mucosa erosion,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1722,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1722,5,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1722,6,Systemic inflammatory response syndrome,Inflammations,General system disorders NEC,Genrl,N
1723,1,Anticonvulsant drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1723,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1724,1,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1725,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1725,2,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
1726,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1726,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1727,1,Documented hypersensitivity to administered product,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1727,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1727,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1727,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1728,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1728,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1728,3,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1728,4,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1728,5,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1728,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1728,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1728,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1729,1,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1729,2,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
1729,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1730,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1731,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1732,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1732,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1733,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1734,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1735,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1735,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1735,3,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1735,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1735,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1736,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1737,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1737,2,Sinus arrest,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1738,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1738,2,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
1738,3,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
1738,4,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
1738,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1738,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1738,7,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1739,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1739,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1739,3,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1739,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1740,1,Documented hypersensitivity to administered product,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1740,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1740,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1740,4,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
1740,5,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1741,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1742,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1742,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1742,3,Eye injury,Eye injuries NEC,Injuries NEC,Inj&P,N
1742,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1742,5,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1742,6,Headache,Headaches NEC,Headaches,Nerv,N
1742,7,Hippocampal sclerosis,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1742,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1742,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1742,10,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1742,11,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1742,12,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1742,13,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1743,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1743,2,Antipsychotic drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1743,3,Antipsychotic drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1743,4,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1743,5,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1743,6,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1743,7,Electroencephalogram abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1743,8,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1743,9,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1743,10,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1743,11,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1743,12,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
1743,13,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1743,14,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1743,15,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1743,16,Physical disability,Disability issues,Lifestyle issues,SocCi,N
1743,17,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1744,1,Hyperkinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1744,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1744,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1744,4,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1744,5,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1744,6,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1745,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1746,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1747,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1747,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1747,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1747,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1748,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1748,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1749,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1749,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1750,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1750,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1751,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1751,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1752,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1752,2,Hyperkinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1752,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1752,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1752,5,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1752,6,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1753,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1753,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1753,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1754,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1754,2,Femoral neck fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1754,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1754,4,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
1755,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1756,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1757,1,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
1758,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1759,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1760,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1760,2,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1761,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1761,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1761,3,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1762,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1762,2,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1762,3,Product preparation error,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1762,4,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1762,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1763,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1763,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1763,3,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1763,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1763,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1763,6,Product preparation error,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1763,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1763,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1764,1,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1764,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1765,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1766,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1766,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1766,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1767,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1767,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1768,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1768,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1768,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1769,1,Aura,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1769,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1769,3,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1769,4,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1769,5,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1769,6,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1769,7,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1770,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1770,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1770,3,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1770,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1771,1,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1771,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1771,3,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1772,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1772,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1773,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1773,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1774,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1774,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1774,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1774,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1774,5,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1774,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1774,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1775,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1775,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1775,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1775,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1776,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1776,2,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1776,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1777,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1778,1,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1778,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1778,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1779,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1780,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1780,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1781,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1781,2,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1782,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1782,2,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1782,3,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1783,1,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1783,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1784,1,Electrocardiogram ST segment elevation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1784,2,Stress cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1785,1,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1785,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1786,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1786,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1787,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1787,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1787,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1787,4,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1787,5,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1787,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1787,7,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1787,8,Eyelid pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1787,9,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1787,10,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1787,11,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1787,12,Grip strength decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1787,13,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1787,14,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1787,15,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1787,16,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1787,17,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1787,18,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
1787,19,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1787,20,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1787,21,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1787,22,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1787,23,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1787,24,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1787,25,Parvovirus B19 infection,Parvoviral infections,Viral infectious disorders,Infec,N
1787,26,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
1787,27,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1787,28,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1787,29,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1787,30,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1787,31,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1787,32,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1787,33,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1787,34,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1787,35,Sputum discoloured,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1787,36,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1787,37,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1787,38,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1787,39,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1787,40,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1788,1,Abnormal sensation in eye,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1788,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1788,3,Macule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1788,4,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1788,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1788,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1788,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1788,8,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1789,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1789,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1789,3,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1789,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1789,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1789,6,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1790,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1791,1,Blood folate decreased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1792,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1793,1,Blood folate decreased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1794,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1795,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1796,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1797,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1797,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1798,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1799,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1799,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1799,3,Epileptic encephalopathy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1799,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1800,1,General physical condition abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1800,2,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1800,3,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
1800,4,Major depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1800,5,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1800,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1800,7,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1801,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1801,2,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1801,3,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1802,1,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1803,1,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1803,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1803,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1804,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1804,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1804,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1804,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1805,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1806,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1806,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1806,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1807,1,Infusion site necrosis,Infusion site reactions,Administration site reactions,Genrl,N
1807,2,Purple glove syndrome,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1808,1,Cerebellar ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1808,2,Poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1809,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1809,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1810,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1810,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1810,3,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1810,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1810,5,Methaemoglobinaemia,Haematological disorders,Haematological disorders NEC,Blood,N
1810,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1810,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1811,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1811,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1811,3,Dysdiadochokinesis,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1811,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1811,5,Past-pointing,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1811,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1812,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1812,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1812,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1812,4,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1812,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1812,6,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1812,7,Fine motor skill dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1812,8,Headache,Headaches NEC,Headaches,Nerv,N
1812,9,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1812,10,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1812,11,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1812,12,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1812,13,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1813,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1813,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1814,1,Cardiogenic shock,Heart failures NEC,Heart failures,Card,Y
1814,2,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1815,1,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1815,2,Methaemoglobinaemia,Haematological disorders,Haematological disorders NEC,Blood,N
1816,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1817,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1817,2,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1818,1,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1818,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1818,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1819,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1820,1,Catheter site pain,Implant and catheter site reactions,Administration site reactions,Genrl,N
1821,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1821,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1821,3,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1821,4,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1821,5,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1822,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1822,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1823,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1824,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1825,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1825,2,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
1825,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1825,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1825,5,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1825,6,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1825,7,Onychoclasis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
1825,8,Thyroxine increased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
1826,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1826,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1826,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1826,4,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1826,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1826,6,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1826,7,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1826,8,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
1826,9,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1826,10,Tongue coated,Tongue signs and symptoms,Tongue conditions,Gastr,N
1827,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1827,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1827,3,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1827,4,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1828,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1828,2,Disorganised speech,Speech and language usage disturbances,Communication disorders and disturbances,Psych,N
1828,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1828,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1829,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1829,2,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
1829,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1829,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1829,5,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1829,6,Exercise tolerance decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1829,7,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1829,8,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1829,9,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1829,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1829,11,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1829,12,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1830,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1831,1,Anticonvulsant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1831,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1832,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1832,2,Polyhydramnios,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
1832,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1832,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1833,1,Anal atresia,Anorectal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
1833,2,Death neonatal,Death and sudden death,Fatal outcomes,Genrl,Y
1833,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1833,4,Oesophageal atresia,Oesophageal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
1833,5,Renal fusion anomaly,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
1833,6,Right ventricular enlargement,Myocardial disorders NEC,Myocardial disorders,Card,N
1833,7,Ventricular septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
1834,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1834,2,Peripheral artery thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1835,1,Bone deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1835,2,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
1835,3,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1835,4,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1836,1,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
1837,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1837,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1837,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1837,4,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1837,5,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
1837,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1837,7,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1837,8,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1837,9,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1838,1,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
1838,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1839,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1840,1,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1840,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1841,1,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
1841,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1842,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1842,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1842,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1842,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1842,5,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1842,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1842,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1843,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1843,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1843,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1843,4,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1843,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1843,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1843,7,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1843,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1843,9,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1844,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1844,2,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1845,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1845,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1845,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1845,4,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1845,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1845,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1845,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1845,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1846,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1846,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1846,3,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
1846,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1846,5,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1846,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1847,1,Fracture pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1848,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1849,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1849,2,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1849,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1850,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1850,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1850,3,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1850,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1850,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1851,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1851,2,Blood albumin increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1851,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1851,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1851,5,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1851,6,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1851,7,Hypoxic-ischaemic encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1851,8,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1851,9,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1851,10,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1851,11,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1851,12,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1851,13,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1851,14,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,Y
1852,1,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
1852,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1853,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1853,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1854,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1855,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1855,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1856,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1856,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1857,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1857,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1857,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1857,4,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
1858,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1858,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1859,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1859,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1859,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1859,4,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1859,5,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1859,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1860,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1860,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1860,3,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1860,4,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
1861,1,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1861,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1862,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1863,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1863,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1863,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1864,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1864,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1864,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1864,4,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1864,5,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1864,6,Breast discomfort,Breast signs and symptoms,Breast disorders,Repro,N
1864,7,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1864,8,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1864,9,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1864,10,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1864,11,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1864,12,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1864,13,Headache,Headaches NEC,Headaches,Nerv,N
1864,14,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1864,15,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1864,16,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1864,17,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1864,18,Myalgia,Muscle pains,Muscle disorders,Musc,N
1864,19,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1864,20,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1864,21,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1864,22,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1864,23,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1864,24,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1864,25,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1865,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1866,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1866,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1866,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1867,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1867,2,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1867,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1868,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1868,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1868,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1869,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1869,2,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1869,3,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1869,4,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1870,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1870,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1870,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
1870,4,Euthyroid sick syndrome,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
1870,5,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1870,6,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1870,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1870,8,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1870,9,Intensive care unit delirium,Deliria,Deliria (incl confusion),Psych,N
1870,10,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1870,11,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1870,12,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
1870,13,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1870,14,Pelvic venous thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1870,15,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1870,16,Ventricular hypokinesia,Myocardial disorders NEC,Myocardial disorders,Card,N
1870,17,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1871,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1871,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1871,3,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1871,4,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1871,5,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1871,6,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1871,7,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1871,8,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1871,9,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1871,10,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1871,11,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1871,12,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1871,13,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1871,14,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1871,15,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1871,16,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1872,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1873,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1873,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1874,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1874,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1874,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1874,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1874,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1875,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1875,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1875,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1875,4,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
1875,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1875,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1875,7,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1875,8,Splenic infarction,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1875,9,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1876,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1876,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1876,3,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1876,4,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1876,5,Migraine,Migraine headaches,Headaches,Nerv,N
1877,1,Auditory disorder,Hearing disorders NEC,Hearing disorders,Ear,N
1877,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1877,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1877,4,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1877,5,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1877,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1878,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1878,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1878,3,Near death experience,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
1879,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1880,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1881,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1881,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1882,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
1882,2,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
1883,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1883,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1883,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1883,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1883,5,Poor peripheral circulation,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1884,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1884,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1884,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1884,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1885,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1885,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1886,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1886,2,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1887,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1887,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1887,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1888,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1889,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1890,1,Hyperglycaemic hyperosmolar nonketotic syndrome,Diabetic complications neurological,Diabetic complications,Metab,Y
1891,1,Anticonvulsant drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1891,2,Anticonvulsant drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1891,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1891,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1892,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1892,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1892,3,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1892,4,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1892,5,Epidermal necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1892,6,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
1892,7,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
1892,8,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1892,9,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1892,10,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1892,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1892,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1893,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1893,2,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1893,3,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1893,4,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
1893,5,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1893,6,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1893,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1893,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1893,9,Urticaria papular,Urticarias,Angioedema and urticaria,Skin,N
1894,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1894,2,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1894,3,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1894,4,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
1894,5,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1894,6,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1894,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1894,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1894,9,Urticaria papular,Urticarias,Angioedema and urticaria,Skin,N
1895,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1895,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1895,3,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
1895,4,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1895,5,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1895,6,Epidermal necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1895,7,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
1895,8,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
1895,9,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1895,10,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1895,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1895,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1895,13,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1896,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1896,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1896,3,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1896,4,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1896,5,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1896,6,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1896,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1896,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1896,9,Urticaria papular,Urticarias,Angioedema and urticaria,Skin,N
1897,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1897,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1897,3,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1897,4,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1897,5,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
1897,6,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1897,7,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1897,8,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1897,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1897,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1897,11,Urticaria papular,Urticarias,Angioedema and urticaria,Skin,N
1898,1,Administration site rash,Administration site reactions NEC,Administration site reactions,Genrl,N
1899,1,Purple glove syndrome,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1900,1,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1901,1,Sjogren's syndrome,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
1902,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1902,2,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1903,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1903,2,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1904,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1905,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1905,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1906,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1906,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1907,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1907,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1907,3,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1907,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1908,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1909,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1909,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1909,3,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1909,4,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1909,5,Haematuria traumatic,Renal and urinary tract injuries NEC,Injuries NEC,Inj&P,N
1909,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1909,7,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1909,8,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1909,9,Muscle contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1909,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1909,11,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1909,12,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1910,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1910,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1910,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
1910,4,Euthyroid sick syndrome,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
1910,5,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1910,6,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1910,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1910,8,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1910,9,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1910,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1910,11,Ventricular hypokinesia,Myocardial disorders NEC,Myocardial disorders,Card,N
1910,12,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1911,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1911,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1911,3,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1911,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1911,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1912,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1912,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1912,3,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1912,4,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1912,5,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1912,6,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1912,7,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1912,8,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1912,9,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1912,10,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1912,11,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1912,12,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1913,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1914,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1914,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1914,3,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1914,4,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1914,5,Haematuria traumatic,Renal and urinary tract injuries NEC,Injuries NEC,Inj&P,N
1914,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1914,7,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1914,8,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1914,9,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1914,10,Muscle contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1914,11,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1914,12,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1914,13,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1915,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1915,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1915,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1915,4,Eye colour change,"Iris and ciliary body structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
1915,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1915,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1915,7,Headache,Headaches NEC,Headaches,Nerv,N
1915,8,Labelled drug-drug interaction issue,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1915,9,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1915,10,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1915,11,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1915,12,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1915,13,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1915,14,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1915,15,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1915,16,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1915,17,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1916,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1916,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1916,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1916,4,Eye colour change,"Iris and ciliary body structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
1916,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1916,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1916,7,Headache,Headaches NEC,Headaches,Nerv,N
1916,8,Labelled drug-drug interaction issue,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1916,9,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1916,10,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1916,11,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1916,12,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1916,13,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1916,14,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1916,15,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1916,16,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1916,17,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1917,1,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
1917,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1917,3,Autonomic nervous system imbalance,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1917,4,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1917,5,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1917,6,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1917,7,Hepatitis fulminant,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1917,8,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1917,9,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1917,10,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1917,11,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1917,12,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1917,13,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1917,14,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1917,15,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1917,16,Pseudomembranous colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
1917,17,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1918,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1918,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1918,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1918,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1918,5,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1918,6,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1918,7,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1918,8,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1918,9,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1919,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1919,2,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
1919,3,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1919,4,Haematuria traumatic,Renal and urinary tract injuries NEC,Injuries NEC,Inj&P,N
1919,5,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1919,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1919,7,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1919,8,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1919,9,Muscle contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1919,10,Pelvic venous thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1919,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1919,12,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1919,13,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1919,14,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1920,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1920,2,Autonomic nervous system imbalance,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1920,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1920,4,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1921,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1921,2,Euthyroid sick syndrome,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
1921,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1921,4,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1921,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1921,6,Intensive care unit delirium,Deliria,Deliria (incl confusion),Psych,N
1921,7,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1921,8,Neuromyopathy,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
1921,9,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1922,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1922,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1922,3,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1922,4,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1922,5,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1922,6,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1922,7,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1922,8,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1922,9,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1922,10,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1922,11,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1923,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1923,2,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1924,1,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1924,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1924,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1924,4,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1924,5,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1924,6,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1924,7,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1924,8,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1924,9,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1924,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1925,1,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1925,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1925,3,Protrusion tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1925,4,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1925,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1926,1,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1926,2,Cerebellar ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1926,3,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1926,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1926,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1926,6,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1926,7,Headache,Headaches NEC,Headaches,Nerv,N
1926,8,Hypometabolism,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
1926,9,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1926,10,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1926,11,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1926,12,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1926,13,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1926,14,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1926,15,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1927,1,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1927,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1927,3,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1927,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1927,5,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1927,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1927,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1928,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1928,2,Extensor plantar response,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1928,3,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1928,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1928,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1929,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1929,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1929,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1929,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1929,5,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1930,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1930,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1930,3,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1930,4,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1930,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1930,6,Impulse-control disorder,Impulse control disorders,Impulse control disorders NEC,Psych,N
1930,7,Intention tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1930,8,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1930,9,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1930,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1931,1,Pyroglutamic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1932,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1932,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1932,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1933,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1934,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1935,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1935,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1936,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1937,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1938,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1939,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1939,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1939,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1939,4,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1939,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1940,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1940,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1940,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1940,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1940,5,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1941,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1941,2,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1941,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1942,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1942,2,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1942,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1943,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1944,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1944,2,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1944,3,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1944,4,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1944,5,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1944,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1944,7,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1944,8,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1944,9,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1944,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1944,11,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1944,12,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1944,13,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1945,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1945,2,Autonomic nervous system imbalance,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1945,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1945,4,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1945,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1945,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1946,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1947,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1948,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1949,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1949,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1949,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1949,4,Hangover,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1949,5,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
1950,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1950,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1950,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1950,4,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1950,5,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1950,6,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1950,7,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1951,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1952,1,Brain death,Death and sudden death,Fatal outcomes,Genrl,Y
1952,2,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1952,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1952,4,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1952,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1952,6,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1952,7,Hyperammonaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
1952,8,Hyperammonaemic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1952,9,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1952,10,Ornithine transcarbamoylase deficiency,Inborn errors of amino acid metabolism,Metabolic and nutritional disorders congenital,Cong,N
1952,11,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1952,12,Unmasking of previously unidentified disease,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1953,1,Anticonvulsant drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1953,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1953,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1954,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1954,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1954,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1954,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1954,5,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1954,6,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1954,7,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1955,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1955,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1955,3,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1955,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1955,5,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1956,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1956,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1956,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1956,4,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1956,5,Atonic seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1956,6,Body temperature fluctuation,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1956,7,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1956,8,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1956,9,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1956,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1956,11,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1956,12,Generalised onset non-motor seizure,Absence seizures,Seizures (incl subtypes),Nerv,N
1956,13,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1956,14,Postictal paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1956,15,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1956,16,Seizure cluster,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1956,17,Sudden unexplained death in epilepsy,Death and sudden death,Fatal outcomes,Genrl,Y
1957,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1958,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1958,2,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1958,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1958,4,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
1958,5,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1958,6,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1958,7,Tonic convulsion,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1959,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1959,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1959,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1959,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1959,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1959,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1960,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1960,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1960,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1960,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1960,5,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1960,6,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1960,7,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1960,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1960,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1960,10,Poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1960,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1960,12,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1961,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1961,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1961,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1961,4,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1961,5,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1961,6,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1961,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1961,8,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1962,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1963,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1964,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1964,2,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1964,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1964,4,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1964,5,Hyperammonaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
1964,6,Hyperammonaemic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1964,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1965,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1966,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1967,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1967,2,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1968,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1969,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1970,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1970,2,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1971,1,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1971,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1971,3,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1971,4,Hyperammonaemic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1971,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1972,1,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1972,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1972,3,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1972,4,Hyperammonaemic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1972,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1973,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1973,2,Hyperammonaemic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1974,1,Headache,Headaches NEC,Headaches,Nerv,N
1975,1,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1976,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1977,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1978,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1978,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1978,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1979,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1980,1,Poor quality product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1980,2,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
1981,1,Hyperammonaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
1982,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
1983,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1983,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1984,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1984,2,Mutism,Communications disorders,Communication disorders and disturbances,Psych,N
1984,3,Optic atrophy,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
1984,4,Quadriplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1984,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1985,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1985,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1985,3,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1985,4,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1986,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1986,2,Infusion site extravasation,Infusion site reactions,Administration site reactions,Genrl,N
1986,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1987,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1987,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1987,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1987,4,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1987,5,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1987,6,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1988,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1988,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1988,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1988,4,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1989,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1989,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1989,3,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1989,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1989,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1989,6,Product appearance confusion,Product confusion errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1989,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1990,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1990,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1990,3,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1990,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1990,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1990,6,Product appearance confusion,Product confusion errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1990,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1991,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1991,2,Hyperammonaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
1992,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1992,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1992,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1993,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1993,2,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1994,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1994,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1994,3,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
1995,1,Cerebellar atrophy,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1995,2,Gingival swelling,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1996,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1997,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1998,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1999,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1999,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2000,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
2001,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2002,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
2003,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2003,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2004,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2005,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2005,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2005,3,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2005,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2006,1,Anticonvulsant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2006,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2007,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
2007,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2007,3,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
2007,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2008,1,Blood folate decreased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2009,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2010,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2010,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2011,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2011,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2012,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2012,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2012,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2012,4,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2013,1,Mean cell volume increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2014,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
2014,2,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
2015,1,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2015,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2015,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2015,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2016,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2016,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2016,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2016,4,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2017,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2017,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2017,3,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
2018,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2018,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2018,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2019,1,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2019,2,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
2019,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2020,1,Bradycardia foetal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2020,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2020,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
2021,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
2021,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2021,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2021,4,New onset refractory status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2021,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2022,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2022,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2023,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2023,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2023,3,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
2023,4,Preterm premature rupture of membranes,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
2023,5,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
2024,1,Bradycardia foetal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2024,2,Foetal dystocia,Foetal position and presentation abnormalities,Foetal complications,Preg,N
2024,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2024,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
2025,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2025,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2025,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
2026,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2026,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2026,3,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
2026,4,Preterm premature rupture of membranes,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
2027,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2028,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2028,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2029,1,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2029,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2029,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2030,1,Cerebral atrophy,Structural brain disorders NEC,Structural brain disorders,Nerv,N
2030,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2030,3,Depersonalisation/derealisation disorder,Dissociative states,Dissociative disorders,Psych,N
2030,4,Echolalia,Stereotypies and automatisms,Changes in physical activity,Psych,N
2030,5,Echopraxia,Stereotypies and automatisms,Changes in physical activity,Psych,N
2030,6,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
2030,7,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,Y
2030,8,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2030,9,"Hallucination, olfactory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2030,10,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2030,11,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
2030,12,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2030,13,Quadriplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
2030,14,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2030,15,Spinal artery thrombosis,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
2030,16,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2031,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2031,2,Drug titration error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2031,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2032,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2033,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2034,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2034,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2035,1,Headache,Headaches NEC,Headaches,Nerv,N
2036,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2037,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2037,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2038,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2039,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2040,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2041,1,Purple glove syndrome,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2042,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2043,1,Blood pressure difference of extremities,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2043,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2044,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
2045,1,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
2045,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2046,1,Blood pressure difference of extremities,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2046,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2046,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2047,1,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
2047,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
